The first bellwether trial over a prescription medication used to treat low testosterone has ended in a mistrial after lead plaintiffs’ attorney Christopher Seeger suffered from heart problems.
U.S. District Judge Matthew Kennelly of the Northern District of Illinois granted an oral motion made by the plaintiffs for a mistrial, according to a minute order on Monday. He scheduled a new trial in the case to begin Sept. 18.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
